TrialMolecular diagnosis & therapy2022

Smad7 Antisense Oligonucleotide-Based Therapy in Crohn's Disease: Is it Time to Re-Evaluate?

Giovanni Monteleone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.